Sukumar Nagendran

Director & President and Head of R&D

Director & President and Head of R&D at Taysha Gene Therapies, Inc., filing insider transactions on 2026-04-10.

Total Purchases

—

0 transactions

Total Sales

$892K

1 transaction

Companies Traded

1 total filings

Active Since

2026-04-10

Last: 2026-04-10

Companies

Taysha Gene Therapies, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-04-10	TSHA	Sale	200.0K	$4.46	$892K	1.14M	SEC ↗